Urgent.News

What's breaking now, across thousands of outlets.

Science

Large meta-analysis sheds new light on how SGLT2 inhibitors affect blood and iron parameters

Research led by internist-nephrologist Dr. Michele Eisenga shows that SGLT2 inhibitors, a class of drugs widely used to treat type 2 diabetes, heart failure and chronic kidney disease, consistently increase hemoglobin and hematocrit levels.

Large meta-analysis sheds new light on how SGLT2 inhibitors affect blood and iron parameters

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

Read the original at medicalxpress.com →

More in Science

More from Monday 26 October →